{Reference Type}: Journal Article
{Title}: The association between depressive symptoms and executive function in type 1 diabetes population: A scoping review.
{Author}: Dandamrongrak C;Rechenberg K;Granger J;Johnson A;Yan K;Kue J;
{Journal}: Prim Care Diabetes
{Volume}: 18
{Issue}: 3
{Year}: 2024 Jun 22
{Factor}: 2.567
{DOI}: 10.1016/j.pcd.2024.04.001
{Abstract}: <B>OBJECTIVE: </B>The purpose of this study was to explore the existing literature on the relationship between depressive symptoms and executive function in patients with type 1 diabetes (T1DM) across the lifespan.<BR><B>METHODS: </B>The scoping review followed the PRISMA protocol by using three databases: PubMed, CINAHL, and PsycINFO on May 14, 2023. Primary research that included reported executive function and the association with depressive symptoms was included in the review.<BR><B>RESULTS: </B>Of 1470 de-duplicated publications identified, nine articles were included in the review. Five studies evaluated the T1DM population, while four studies evaluated T1DM and type 2 diabetes (T2DM) as an aggregate result. Three studies indicated an association between depressive symptoms and executive function in adults with T1DM, and four studies indicated an association between depressive symptoms and executive function in adults with either T1DM or T2DM. In general, participants who reported depressive symptoms also exhibited poor executive function. However, two studies did not find an association between depressive symptoms and executive function.<BR><B>CONCLUSIONS: </B>In summary, the seven studies in this review suggest that individuals with T1DM who report depressive symptoms are at a higher risk of poor executive function; a clear association between depressive symptoms and executive function in individuals with T1DM remains inconclusive. There is a need to explore this relationship in the future.